| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |